Trends in Oral Anticoagulant Use and Individual Expenditures Across the United States from 2014 to 2020.

Omar S AlkheziLeo F BuckleyJohn Fanikos

Published in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2024)

DOACs have replaced warfarin as the preferred OAC in the US. The increased costs associated with DOAC use may decline when generic formulations are approved.

Keyphrases

direct oral anticoagulants
venous thromboembolism
atrial fibrillation
drug administration
health insurance
oral anticoagulants